Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()

Prostate cancer is a leading cause of cancer death in men in developed countries. Once the tumor has achieved a castration-refractory metastatic stage, treatment options are limited with the average survival of patients ranging from two to three years only. Recently, new drugs for treatment of castr...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidegger, Isabel, Massoner, Petra, Eder, Iris E., Pircher, Andreas, Pichler, Renate, Aigner, Friedrich, Bektic, Jasmin, Horninger, Wolfgang, Klocker, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834152/
https://www.ncbi.nlm.nih.gov/pubmed/23792785
http://dx.doi.org/10.1016/j.jsbmb.2013.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834152/
https://www.ncbi.nlm.nih.gov/pubmed/23792785
http://dx.doi.org/10.1016/j.jsbmb.2013.06.002

Ejemplares similares